An introduction to the Marburg virus vaccine consortium, MARVAC.
Saved in:
| Title: | An introduction to the Marburg virus vaccine consortium, MARVAC. |
|---|---|
| Authors: | Cross RW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Longini IM; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America., Becker S; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany., Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Boucher D; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America., Carroll MW; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom., Díaz JV; World Health Organization, Geneva, Switzerland., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America., Draghia-Akli R; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America., Duworko JT; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia., Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Egan MA; Auro Vaccines, Pearl River, New York, United States of America., Fast P; IAVI, New York, New York, United States of America., Finan A; Sabin vaccine Institute, Washington, DC, United States of America., Finch C; Sabin vaccine Institute, Washington, DC, United States of America., Fleming TR; University of Washington, Seattle, Washington, United States of America., Fusco J; Public Health Vaccines, Cambridge, Massachusetts, United States of America., Geisbert TW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Griffiths A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Hensley LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America., Honko A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Hunegnaw R; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Jakubik J; Sabin vaccine Institute, Washington, DC, United States of America., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Luhn K; Janssen Vaccines & Prevention, Leiden, the Netherlands., Matassov D; Auro Vaccines, Pearl River, New York, United States of America., Meshulam J; Auro Vaccines, Pearl River, New York, United States of America., Nelson EV; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Parks CL; IAVI, New York, New York, United States of America., Rustomjee R; Sabin vaccine Institute, Washington, DC, United States of America., Safronetz D; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Schwartz LM; World Health Organization, Geneva, Switzerland., Smith D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Smock P; Sabin vaccine Institute, Washington, DC, United States of America., Sow Y; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Warfield KL; Emergent BioSolutions, Gaithersburg, Maryland, United States of America., Wolfe D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Woolsey C; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Zahn R; Janssen Vaccines & Prevention, Leiden, the Netherlands., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36227853 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An introduction to the Marburg virus vaccine consortium, MARVAC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cross+RW%22">Cross RW</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Longini+IM%22">Longini IM</searchLink>; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America.<br /><searchLink fieldCode="AU" term="%22Becker+S%22">Becker S</searchLink>; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bok+K%22">Bok K</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Boucher+D%22">Boucher D</searchLink>; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Carroll+MW%22">Carroll MW</searchLink>; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Díaz+JV%22">Díaz JV</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dowling+WE%22">Dowling WE</searchLink>; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Draghia-Akli+R%22">Draghia-Akli R</searchLink>; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22Duworko+JT%22">Duworko JT</searchLink>; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia.<br /><searchLink fieldCode="AU" term="%22Dye+JM%22">Dye JM</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Egan+MA%22">Egan MA</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+P%22">Fast P</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Finan+A%22">Finan A</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Finch+C%22">Finch C</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Fleming+TR%22">Fleming TR</searchLink>; University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Fusco+J%22">Fusco J</searchLink>; Public Health Vaccines, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Geisbert+TW%22">Geisbert TW</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Griffiths+A%22">Griffiths A</searchLink>; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Günther+S%22">Günther S</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hensley+LE%22">Hensley LE</searchLink>; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Honko+A%22">Honko A</searchLink>; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hunegnaw+R%22">Hunegnaw R</searchLink>; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Jakubik+J%22">Jakubik J</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Ledgerwood+J%22">Ledgerwood J</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Luhn+K%22">Luhn K</searchLink>; Janssen Vaccines & Prevention, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Matassov+D%22">Matassov D</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Meshulam+J%22">Meshulam J</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Nelson+EV%22">Nelson EV</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Parks+CL%22">Parks CL</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Rustomjee+R%22">Rustomjee R</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Safronetz+D%22">Safronetz D</searchLink>; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Schwartz+LM%22">Schwartz LM</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Smock+P%22">Smock P</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Sow+Y%22">Sow Y</searchLink>; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Spiropoulou+CF%22">Spiropoulou CF</searchLink>; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.<br /><searchLink fieldCode="AU" term="%22Sullivan+NJ%22">Sullivan NJ</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Warfield+KL%22">Warfield KL</searchLink>; Emergent BioSolutions, Gaithersburg, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Wolfe+D%22">Wolfe D</searchLink>; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Woolsey+C%22">Woolsey C</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Zahn+R%22">Zahn R</searchLink>; Janssen Vaccines & Prevention, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Henao-Restrepo+AM%22">Henao-Restrepo AM</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Muñoz-Fontela+C%22">Muñoz-Fontela C</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Marzi+A%22">Marzi A</searchLink>; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. <i>Date of Electronic Publication: </i>2022 Oct 13 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36227853 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1010805 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1010805 Titles: – TitleFull: An introduction to the Marburg virus vaccine consortium, MARVAC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cross RW – PersonEntity: Name: NameFull: Longini IM – PersonEntity: Name: NameFull: Becker S – PersonEntity: Name: NameFull: Bok K – PersonEntity: Name: NameFull: Boucher D – PersonEntity: Name: NameFull: Carroll MW – PersonEntity: Name: NameFull: Díaz JV – PersonEntity: Name: NameFull: Dowling WE – PersonEntity: Name: NameFull: Draghia-Akli R – PersonEntity: Name: NameFull: Duworko JT – PersonEntity: Name: NameFull: Dye JM – PersonEntity: Name: NameFull: Egan MA – PersonEntity: Name: NameFull: Fast P – PersonEntity: Name: NameFull: Finan A – PersonEntity: Name: NameFull: Finch C – PersonEntity: Name: NameFull: Fleming TR – PersonEntity: Name: NameFull: Fusco J – PersonEntity: Name: NameFull: Geisbert TW – PersonEntity: Name: NameFull: Griffiths A – PersonEntity: Name: NameFull: Günther S – PersonEntity: Name: NameFull: Hensley LE – PersonEntity: Name: NameFull: Honko A – PersonEntity: Name: NameFull: Hunegnaw R – PersonEntity: Name: NameFull: Jakubik J – PersonEntity: Name: NameFull: Ledgerwood J – PersonEntity: Name: NameFull: Luhn K – PersonEntity: Name: NameFull: Matassov D – PersonEntity: Name: NameFull: Meshulam J – PersonEntity: Name: NameFull: Nelson EV – PersonEntity: Name: NameFull: Parks CL – PersonEntity: Name: NameFull: Rustomjee R – PersonEntity: Name: NameFull: Safronetz D – PersonEntity: Name: NameFull: Schwartz LM – PersonEntity: Name: NameFull: Smith D – PersonEntity: Name: NameFull: Smock P – PersonEntity: Name: NameFull: Sow Y – PersonEntity: Name: NameFull: Spiropoulou CF – PersonEntity: Name: NameFull: Sullivan NJ – PersonEntity: Name: NameFull: Warfield KL – PersonEntity: Name: NameFull: Wolfe D – PersonEntity: Name: NameFull: Woolsey C – PersonEntity: Name: NameFull: Zahn R – PersonEntity: Name: NameFull: Henao-Restrepo AM – PersonEntity: Name: NameFull: Muñoz-Fontela C – PersonEntity: Name: NameFull: Marzi A IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 10 Text: 2022 Oct 13 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 18 – Type: issue Value: 10 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |